Pharma

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Par Pharmaceutical Companies, Inc. announced that it began shipping calcitonin-salmon nasal spray to the trade. Calcitonin-salmon nasal spray is a generic version of Novartis' Miacalcin. Annual U.S. sales of Miacalcin were approximately $112 million in 2008, according to IMS Health data.

Today in Marketing/Media/ROI...keeping you current

Personalized Medicine Market To Grow 11% Annually
PharmExec, 12/15/09

Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/15/09

Alcon to Enter Surgical Glaucoma Market by Acquiring Optonol
Alcon, 12/15/09